NCT01444586 - Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE) | Biotech Hunter

Enrollment

2,293

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

July 31, 2014

Conditions

Arthroplasty, Replacement, HipArthroplasty, Replacement, Knee

Interventions

DRUG

Rivaroxaban (Xarelto, BAY59-7939)

The patients will be treated according to the routine practice. All the patients meeting the criteria of inclusion and exclusion to whom administration of Xarelto is indicated are fit for participation in this non-interventional study.

Trial Locations (1)

Unknown

Many Locations